APHY - Assured Pharmacy Reports Results for the Fiscal Year

New Post Public Reply Private Reply Replies (1) Message Board
SevenTenEleven tommyboyboy #1458

APHY - Assured Pharmacy Reports Results for the Fiscal Year 2011 

Wednesday 4 April 2012 


Assured Pharmacy (APHY: pinksheets), a leading specialty pharmacy group providing prescription medications to sufferers of chronic pain, announced net sales of $16,444,573 for the year ended December 31, 2011, an increase of $167,821 or 1.0%, from $16,276,752 for the year ended December 31, 2010. Basic and diluted net loss per share was $1.14 for the year 2011, a 54.0% improvement compared to $2.48 net loss per share in the same period in 2010. 

The increase in sales for the year 2011 compared to the year 2010 was primarily due to an increase in the number of patients serviced as a result of our continued direct sales efforts and to a much lesser extent the opening of our 5th pharmacy in the Kansas City metropolitan area in November 2011. The increase in revenue from increased patients was partially offset by a decrease in revenue per prescription due to increased generic utilization by our patients and to a lesser extent a decrease in management service fee revenue of $160,005. As a result of the increase in generic utilization, our gross profit margins on pharmacy revenue increased to 19.1% for the year 2011 up from 17.6% for the year 2010. The number of prescriptions filled by our pharmacies increased by 6,300 prescriptions or 5.7%, with 117,410 prescriptions filled in the year ended December 31, 2011, as compared to 111,110 prescriptions filled in the year 2010. 

We are pleased with the year over year performance improvement in our operations for the year 2011 and the opening our new pharmacy in Kansas. The opening of our new pharmacy and improved operating results reflect continued progress in the implementation of our strategies and provide further validation of our business model as we move forward with the expansion of our business," said Robert DelVecchio, Chief Executive Officer of Assured Pharmacy. 

The audited financial statements for the years ended December 31, 2011, and 2010 have been posted on the OTC Markets website and are available at www.otcmarkets.com under our trading symbol, APHY. 

About Assured Pharmacy, Inc. 

Assured Pharmacy, Inc. is a growing provider of specialty pharmacy services to patients and physicians in the treatment of chronic pain. Through its network of specialty pharmacies, the Company predominantly dispenses highly regulate pain mediations to sufferers of chronic pain, while stringently adhering to federal and state reporting requirements for both patients and physicians. The Company derives its revenue primarily from the sale of prescription drugs and does not keep in inventory non-prescription drugs or health and beauty related products inventoried at traditional pharmacies. The majority of the Company's business is derived from repeat visits from its customer base of physician-referred chronic pain patients. "Walk-in" prescriptions from physicians are limited. The Company currently has five operating pharmacies which are wholly owned including its fifth operating pharmacy in the Kansas City metropolitan area which opened in November 2011. 

Safe Harbor Statement 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. A wide variety of factors that may cause actual results to differ from the forward-looking statements include, but are not limited to, the following: the Company's ability to increase revenue and profits in the current economic climate; the effect of changing economic conditions; lack of sufficient financing for opening new pharmacies; inability to manage growth; and changes in government regulations, controls and similar matters. These cautionary statements should not be construed as exhaustive or as any admission as to the adequacy of the Company's disclosures. The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements. The reader should consider statements that include the words "believes," "expects," "anticipates," "intends," "estimates," "plans," "projects," "should," or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking. The Company does not undertake to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise. 

Investor Contact: 

Erika Moran/Adam Holdsworth 
The Investor Relations Group 
11 Stone St. 3rd Floor 
New York, NY 
212-825-3210 
SOURCE Assured Pharmacy, Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Medicare Payment Proposal Faces Doctor Backlash in D.C.

Updated Category News Views 5

Why Same-Day Medicare Care Matters Imagine you're gasping for breath, struggling to find relief, and then being told to wait weeks for care. It's not just an inconvenience; it's a health hazard. This isn't some arbitrary tale—it's the gritty reality for folks relying on same-day care. A group of docs and advocates recently stormed Capitol Hill sounding the alarm about a...

Continue Reading
Comparent Unveils Key Insights with Top 100 List

Updated Category News Views 4

The Ebb and Flow of Vacation Rental Giants Ever noticed how some industries just sneak up and suddenly transform landscapes? Vacation rental management is one of those sneaky offenders. At the forefront of keeping tabs on this bustling sector, Comparent just dropped a meaty second annual roster—the Comparent 100—showcasing the biggest players flexing their muscles in...

Continue Reading
Local Expertise in Real Estate: Key to Success?

Updated Category News Views 4

Local Market Know-How: A Seller's Best Asset So you're thinking about selling your home in North Carolina, huh? Here's a tip—get yourself a local real estate pro who knows the ins and outs of your neighborhood like the back of their hand. Michael McCollum, a prominent voice from Reidsville, NC, highlights how crucial local expertise can be in navigating the widely...

Continue Reading
Reel Wheels: Hollywood's Iconic Car Collection Unveiled

Updated Category News Views 4

Rolling Out the Legends: A Peek Inside Reel Wheels Picture something that screams Hollywood. Now, give it wheels, maybe some wings too. That's what Reel Wheels Entertainment has laid out—a mind-boggling assortment of film and TV vehicles. Released on September 30, 2026, this collection is a treasure trove of Hollywood's on-screen memorabilia, and they're not just...

Continue Reading
Gateway Unveils All-In-One Award Travel Platform

Updated Category News Views 3

Transforming Loyalty with point.me's Gateway Here's the deal: the loyalty program game just changed. Point.me rolled out this slick beast called Gateway, and it's weaving award travel booking right into your everyday banking apps. That's right, ditch those clunky third-party sites, because now you can browse, compare, transfer, and book your award travel directly from...

Continue Reading
Neutonic Sets Sights on U.S. with Walmart Expansion

Updated Category News Views 4

Neutonic Embarks on Major Expansion with Walmart Well, here we go. Neutonic is stepping up to the big leagues by planting its flag in nearly 1,000 Walmart stores across the U.S. This move lands them right in the thrumming heart of Walmart's new Mood & Mind beverage set. It's about time this brand brings its functional beverages to American shoppers already drained by...

Continue Reading
Hyundai's Record Q3 Sales: SUVs and Hybrids Lead

Updated Category News Views 1

Hyundai's Drive to Record Q3 Sales When talking about market moves, Hyundai's recent figures speak louder than most quarterly bells. September 2026 marked a whirlwind of growth for Hyundai Motor America, reporting record-breaking sales numbers not just for the month, but for Q3 as a whole. With a 9% jump from September last year in total vehicle sales and a remarkable 3%...

Continue Reading
Nelson-Jameson Boosts Cold Storage in California Move

Updated Category News Views 1

An Icy Boost for the West Coast Dairy Player Every now and then, a company gets its cold storage game just right. Nelson-Jameson has added fresh muscle to its Turlock facility in California, making waves with serious logistical upgrades. The company's dogged pursuit of better operational efficiency in dairy processing isn't just about bragging rights. It's plain old good...

Continue Reading
EPR Fireworks, Schedule2.IT Enhance EMS Integration

Updated Category News Views 6

Joining Forces for Effective EMS Management In a move that could shake up emergency medical services, EPR Fireworks has teamed up with Schedule2.IT to amp up integration. This Florida-based partnership is all about breaking down those bureaucratic firewalls between patient care and controlled substances tracking. They’re pushing for a seamless workflow, where crucial...

Continue Reading
OSHA and NSC Forge Alliance to Prevent Worksite Tragedies

Updated Category News Views 4

Forging Ahead With a Crucial Collaboration Ins, outs, ups, and downs—safety shouldn’t get lost in the shuffle, but it does. In steps the National Serious Injury and Fatality Prevention Alliance, a fresh partnership convened by OSHA with the National Safety Council—hop on board or get left behind mindsets. We’re talking about real, heads-down, hard-hitting actions...

Continue Reading

Top 5 Most Recently Viewed Articles

Nokia and Indosat Ooredoo Hutchison's New Network Expansion Strategy

Updated Category News Views 181

Nokia and Indosat Ooredoo Hutchison's Strategic Partnership Nokia has formally announced an exciting extension of its partnership with Indosat Ooredoo Hutchison (IOH) aimed at expanding the telecommunications network across Indonesia. This collaboration seeks to address the growing demands for advanced mobile connectivity as technology continues to evolve rapidly. Key...

Continue Reading
Empowering Education: HCC's $200k Grant from PepsiCo Foundation

Updated Category News Views 70

Howard Community College Receives $200,000 Grant Howard Community College (HCC) has exciting news: it has received a substantial $200,000 grant from the PepsiCo Foundation. This marks the second year in a row that HCC has secured this vital funding, bringing the total support from the foundation to $300,000. This grant will help HCC continue its mission of providing...

Continue Reading
Hemen Holding Limited Transfers Significant Stake in Golden Ocean

Updated Category News Views 209

Hemen Holding Limited Sells Stake in Golden Ocean Group Limited In a significant move within the drybulk shipping industry, Hemen Holding Limited has announced the sale of 81,363,730 shares in Golden Ocean Group Limited (NASDAQ/OSE: GOGL) to CMB.TECH (NYSE: CMBT). This transaction, valued at approximately USD 1,179 million, allows Hemen to divest around 40.8% of Golden...

Continue Reading
AutoNation Announces Major Stock Repurchase Plan Expansion

Updated Category News Views 172

AutoNation Expands Its Share Repurchase Initiative AutoNation, Inc. (NYSE: AN), a leading automotive retailer in the United States, has made a significant announcement regarding its stock repurchase strategy. The company’s Board of Directors has authorized the repurchase of an additional $1 billion of AutoNation's common stock, reinforcing its commitment to increasing...

Continue Reading
Rona Therapeutics' New Phase 2 Study Marks a Significant Milestone

Updated Category News Views 388

Rona Therapeutics Moves Forward with Promising Clinical Trials Rona Therapeutics Inc., a trailblazer in RNA-targeted therapies, recently announced that it has received clearance for an Investigational New Drug (IND) from the U.S. Food and Drug Administration (FDA) to start a Phase 2 clinical study for its drug RN0361. This medication is designed to target APOC3 and is...

Continue Reading